**Graduation Date:** Undergraduate: 1984 **Professional Affiliations:** Member of the Nephrology Committee of Guangdong Medical Association; Member of the Science and Technology Expert Committee of Guangdong Provincial Population and Family Planning Commission; University-level Cultivation Talent of the Second Phase of the Guangdong Province "Thousand, Hundred, Ten" Project. **Research Grants:** 1. Effect of MIF Antisense RNA on Pathological Changes in Experimental Lupus Nephritis. National Natural Science Foundation of China. 100,000 RMB. Principal Investigator. 1998. 2. Effect of MIF Antisense RNA and MIF Antibody on Pathological Changes in Experimental Crescentic Glomerulonephritis. Research Grant from Guangdong Provincial Health Department. 5,000 RMB. Principal Investigator. 1998. 3. Novel Pathogenesis and Prevention/Treatment of Steroid-Resistant Glomerulonephritis. Key Project Grant from Guangdong Provincial Science and Technology Commission. 60,000 RMB. Second Principal Investigator. 1998. 4. Study on TLI-Immunosuppressive Combination Therapy for Renal Transplantation in Highly Sensitized Patients. University Research Grant. 10,000 RMB. Principal Investigator. 1994. 5. Expression of Osteopontin in Human Glomerulonephritis and Its Clinical Diagnostic Value. Research Grant from Guangdong Provincial Health Department. 10,000 RMB. Third Principal Investigator. 1998. 6. Effect of Detoxification and Blood-Activating Method on PPAR-γ Signaling Pathway in Lupus Nephritis. National Natural Science Foundation of China. 200,000 RMB. Second Principal Investigator. Approval No. 30271668. 2003. 7. Investigating the Effect of Lupus Formula on Lupus Nephritis via PPAR-γ-Mediated Negative Regulation of Inflammatory Response. Doctoral Program Foundation of Ministry of Education of China. Second Principal Investigator. 2003. Project No. 20020558051. 8. Effect of MIF Antisense Oligonucleotide on Pathological Damage in Experimental Lupus Nephritis. Natural Science Foundation of Guangdong Province. Principal Investigator. Project No. 04009432. 2004. 9. Role of TNFα/TNFRs Signal Deviation in the Formation of TCM Syndromes in Systemic Lupus Erythematosus. National Natural Science Foundation of China. 2005. Second Principal Investigator. **Awards:** 1. Pathogenesis and Clinical Study of Lupus Nephritis. Third Prize of the Ministry of Health Science and Technology Progress Award. Ranked 4th. 1998. 2. Pathogenesis and Clinical Study of Lupus Nephritis. Third Prize of the Guangdong Provincial Health Department Science and Technology Achievement Award. Ranked 4th. 1998. 3. Basic and Clinical Comprehensive Study of Acute Renal Failure. Third Prize of University Science and Technology Achievement Award. Ranked 2nd. 1994. 4. Study on the Mechanism of Macrophage Accumulation in Glomerular Diseases. Nominated for the Second Prize of the Ministry of Education Science and Technology Award. 2005. 5. Pathogenic Role and Regulatory Factors of Osteopontin in Glomerulonephritis. Second Prize of the Chinese Medical Association Award. 2001. 6. Role of Osteopontin in the Pathogenesis of Experimental Crescentic Glomerulonephritis. First Prize of the China University Science and Technology Progress Award. 2001. 7. Series Studies on the Pathogenic Role of Inflammatory Cells and Inflammatory Factors in Glomerular Diseases. Third Prize of the Guangdong Provincial Science and Technology Progress Award. 2006. 8. Study on the Mechanism of Macrophage Accumulation in Glomerular Diseases. Second Prize of the Guangdong Provincial Science and Technology Award. 2006. **Publications:** 1. Effect of urinary IgG from patients with two pathological types of nephropathy on macrophage migration inhibitory factor expression in human renal tubular epithelial cells. *Chinese Journal of Nephrology*. July 2005. First author. 2. Effect of anti-sense oligonucleotide on expression of MIF in macrophage. *Journal of Microbiology and Immunology*. February 2005. First author. 3. Expression of macrophage migration inhibitory factor in peripheral blood mononuclear cells and its correlation with lupus activity. *Chinese Journal of Internal Medicine*. August 2004. First author. 4. Relationship between urinary macrophage migration inhibitory factor concentration and renal tissue damage in lupus nephritis. *Chinese Journal of Nephrology*. April 2004. First author. 5. Expression and role of macrophage migration inhibitory factor in chronic graft-versus-host disease lupus-like nephritis. *Chinese Journal of Rheumatology*. February 2002. First author. 6. Expression and significance of matrix metalloproteinase-2 and -9 in renal tissue of patients with lupus nephritis. *Chinese Journal of Critical Care Medicine*. July 2002. First author. 7. Effect of anti-sense oligonucleotide on expression of MIF in macrophage. *Journal of the American Society of Nephrology*. October 2002. First author. 8. Urine macrophage migration inhibitory factor reflects the renal MIF expression and the severity of renal injury in human lupus nephritis. *Journal of the American Society of Nephrology*. October 2004. First author. 9. The expression of macrophage migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity. *Journal of the American Society of Nephrology*. October 2004. First author. 10. The effect of from nephritic patients on expression of macrophage migration inhibitory factor in human proximal tubular epithelial cells. *Journal of the American Society of Nephrology*. October 2005. First author. 11. Urinary albumin from nephritic syndrome patients up-regulates endothelin-1 expression in human proximal tubular epithelial cells. *Journal of the American Society of Nephrology*. October 2005. First author. **Books:** 1. *Fluid Therapy*. Shanghai Scientific and Technical Publishers. 2000. Editor-in-Chief. 2. *Clinical Diagnostics for General Practitioners*. Science Press. 2001. 3. *Practical Emergency Prescription Medication Manual*. Guangdong Science and Technology Press. 2002. 4. *Nephrotic Syndrome*. People's Medical Publishing House. January 2005.